Hamps Bio Limited IPO

Hamps Bio Limited, incorporated in 2007, is a dynamic company that is engaged in marketing & distribution of a diverse pharmaceutical product range, like syrups, injectables, capsules, oils, nutritional supplements and more. Having a steadfast commitment to innovation and quality, Hamps BIO has also established itself as a trusted name within the pharmaceutical industry.

Distribution Network:

Hamps Bio Limited boasts an extensive distribution network encompassing approximately 50 distributors and varied e-commerce platforms. The products they offer are available on varied reputable online marketplaces, including Amazon in the EU, Canada, and the US. Apart from that, the products are also available in India on Jio Mart and Flipkart. Maintaining expansive reach with the offered products ensures that the pharma offerings by Hamps Bio remain accessible to a broad consumer range. Their pharma products are sold across the eight states and the Indian Union territories. Moreover, their freeze-dried and frozen products have a broader geographical reach, extending to 22 states and union territories of 6 countries.

Business Segments:

Hamps Bio Limited's operations have been strategically divided into two major segments:

Pharmaceuticals

Operating under the "Hamps" brand, the company's pharmaceutical division delivers a comprehensive product array. Such a segment includes syrups, tablets, injectables, capsules, and also powders. All of it is meticulously crafted to meet high standards of both safety and efficacy.

Freeze-dried and Frozen Products

The FMCG division of the company focuses on freeze-dried & frozen items. These are marketed under the "FzyEzy" brand. Hamps Bio today operates via both B2C and B2B models, offering products under the brand and even engaging within contract manufacturing. The freeze-dried & frozen product line includes varied options like strawberries, mango, jamun and chikoo powder, catering to both international and domestic demands.

To summarize, Hamps Bio Limited continues its expansion today by having a footprint in not just pharmaceutical but also FMCG sectors. It is driven by innovation & customer satisfaction.

Hamps Bio IPO Overview:

• Issue Type: Fixed Price Issue IPO
• IPO Size: ₹6.22 crores
• Fresh Issue: 12.2 lakh shares
• Price Per Share: ₹51
• Minimum Lot Size: 2000 shares
• IPO Opening Date: December 13, 2024
• IPO Closing Date: December 17, 2024
• Book Running Lead Managers: Marwadi Chandarana Intermediaries Brokers Pvt. Ltd.
• Registrar: Bigshare Services Pvt. Ltd.
• Market Maker: Pure Broking